Targeted Sequencing And Resequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Sequencing, Re-sequencing( Electrophoresis-based resequencing, NGS, Array-based resequencing)), By Type (DNA-based targeted sequencing, RNA-based targeted sequencing), By Application (Clinical application, Plant and animal sciences, Drug development, Others), By End use (Hospitals & clinics, Academic research, Others), By Region and Competition, 2019-2029F

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Forecast Period

2025-2029

Market Size (2023)

USD 5.11  Billion

CAGR (2024-2029)

5.25%

Fastest Growing Segment

Sequencing

Largest Market

North America

Market Size (2029)

USD 6.21 Billion

Market Overview

Global Targeted Sequencing And Resequencing Market was valued at USD 5.11 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. Targeted sequencing and resequencing have emerged as essential tools in genomics research, enabling scientists to delve deeper into the intricacies of genetic variations with unprecedented precision. These techniques hold immense promise in elucidating disease mechanisms, identifying therapeutic targets, and facilitating personalized medicine approaches. As the demand for genomic insights continues to grow, the global targeted sequencing and resequencing market witnessed significant expansion, driven by technological advancements and increasing applications across diverse sectors.

The global targeted sequencing and resequencing market has experienced robust growth in recent years, propelled by the burgeoning adoption of next-generation sequencing (NGS) technologies and a rising emphasis on personalized healthcare solutions. Targeted sequencing involves selectively sequencing specific regions of interest within the genome, offering enhanced efficiency and cost-effectiveness compared to whole-genome sequencing. On the other hand, resequencing involves the comparison of an individual's genome to a reference genome, facilitating the detection of genetic variations associated with diseases or traits.

Key Market Drivers

Rising Investments in Precision Medicine is Driving the Global Targeted Sequencing And Resequencing Market

Precision medicine, a groundbreaking approach that tailors medical treatment to individual characteristics, is revolutionizing healthcare. At the forefront of this revolution is targeted sequencing and resequencing, technologies that allow for the precise analysis of genetic information. As investments in precision medicine soar, the global targeted sequencing and resequencing market is experiencing unprecedented growth. Precision medicine represents a paradigm shift in healthcare, moving away from the traditional one-size-fits-all approach to treatments and diagnostics. By leveraging advances in genomics, proteomics, and other omics technologies, precision medicine seeks to understand the unique genetic makeup of each patient and tailor medical interventions accordingly. This personalized approach holds the promise of more effective treatments with fewer side effects, ultimately improving patient outcomes.

At the heart of precision medicine lies the ability to accurately sequence and analyze the genome. Targeted sequencing and resequencing are powerful techniques that enable researchers and clinicians to examine specific regions of the genome with unparalleled precision. Targeted sequencing focuses on sequencing predetermined regions of interest, such as genes associated with specific diseases or drug responses. Resequencing, on the other hand, involves comparing an individual's genome to a reference genome to identify variations or mutations.

Growing Demand for Research Tools and Services is Driving the Global Targeted Sequencing And Resequencing Market

Genomic research has become integral to various scientific disciplines, including healthcare, agriculture, forensics, and evolutionary biology. The ability to sequence and analyze specific regions of the genome with high accuracy and efficiency has revolutionized our understanding of genetic variations, disease mechanisms, and evolutionary relationships. Targeted sequencing and resequencing techniques, such as polymerase chain reaction (PCR) amplification, hybridization capture, and amplicon sequencing, have significantly contributed to advancing genomic studies by allowing researchers to focus on specific regions of interest.

With the growing emphasis on personalized medicine, there is an increasing need to identify genetic variants associated with diseases, drug responses, and treatment outcomes. Targeted sequencing facilitates the identification of relevant genetic markers with high specificity and sensitivity, paving the way for tailored therapeutic interventions. Cancer is a genetically heterogeneous disease characterized by complex molecular alterations. Targeted sequencing enables comprehensive profiling of cancer genomes, leading to the discovery of driver mutations, assessment of tumor heterogeneity, and identification of potential therapeutic targets. As precision oncology gains traction, the demand for targeted sequencing in cancer research and clinical diagnostics continues to rise.

In agriculture, targeted sequencing plays a crucial role in crop improvement, livestock breeding, and biodiversity conservation. By analyzing specific genomic regions associated with desirable traits such as yield, disease resistance, and nutritional content, researchers can accelerate the development of genetically superior crops and livestock breeds, contributing to global food security and sustainability. Rapid and accurate detection of pathogens is essential for disease surveillance, outbreak investigation, and public health response. Targeted sequencing enables the selective amplification and sequencing of microbial genomes, facilitating the identification and characterization of infectious agents, including bacteria, viruses, and parasites. This capability is particularly valuable in monitoring emerging infectious diseases and tracking transmission dynamics.

Download Free Sample Report

Key Market Challenges

Data Analysis and Interpretation

Another significant hurdle in the global targeted sequencing and resequencing market is the complexity of data analysis and interpretation. The massive amount of sequencing data generated from these techniques requires sophisticated bioinformatics tools and expertise to extract meaningful insights. Analyzing sequencing data involves various steps, including read alignment, variant calling, and annotation, each of which presents its own set of challenges.

To address this issue, there is a growing demand for user-friendly bioinformatics software that can streamline data analysis workflows and provide actionable results. Additionally, there is a need for specialized training programs and workshops to educate researchers and clinicians on best practices for data analysis and interpretation.

Standardization and Quality Control

Ensuring the accuracy and reproducibility of sequencing results is crucial for the success of targeted sequencing and resequencing applications, particularly in clinical settings where decisions regarding patient care may be based on sequencing data. However, achieving consistent results across different sequencing platforms and laboratories remains a significant challenge due to the lack of standardized protocols and quality control measures.

Industry organizations and regulatory agencies play a vital role in addressing this challenge by developing guidelines and standards for sample preparation, sequencing protocols, and data analysis pipelines. Additionally, the implementation of rigorous quality control measures, such as regular performance monitoring and proficiency testing, can help ensure the reliability of sequencing results.

Key Market Trends 

Technological Advancements

In recent years, the field of genomics has witnessed a rapid evolution, driven largely by advancements in sequencing technologies. One of the most significant developments in this realm is targeted sequencing and resequencing, which allows researchers to focus on specific regions of the genome with high precision and accuracy. This technology has revolutionized various aspects of genetic research, including disease diagnosis, drug discovery, and personalized medicine. As a result, the global targeted sequencing and resequencing market is experiencing substantial growth, propelled by the increasing demand for efficient and cost-effective genomic analysis tools.

Targeted sequencing involves the selective amplification and sequencing of specific regions of interest within the genome. This approach offers several advantages over whole-genome sequencing, including reduced costs, faster turnaround times, and higher sequencing depth, leading to greater sensitivity for detecting genetic variations. By targeting only relevant genomic regions, researchers can efficiently interrogate specific genes or genomic regions associated with particular diseases or traits.

Resequencing, on the other hand, involves the comparison of an individual's genome to a reference genome to identify genetic variations, such as single nucleotide polymorphisms (SNPs), insertions, deletions, and structural variants. This enables researchers to study genetic diversity within populations, identify disease-causing mutations, and understand the genetic basis of complex traits.

The growing adoption of targeted sequencing and resequencing technologies can be attributed to several factors. Firstly, advancements in sequencing platforms, such as next-generation sequencing (NGS) and third-generation sequencing technologies, have significantly enhanced the speed, accuracy, and cost-effectiveness of genomic analysis. These platforms offer higher throughput, increased read lengths, and improved sequencing chemistry, allowing researchers to generate large volumes of sequencing data with unprecedented accuracy and resolution.

Furthermore, the development of innovative library preparation methods, sequencing chemistries, and bioinformatics tools has further streamlined the targeted sequencing and resequencing workflow, making it more accessible to researchers with diverse backgrounds and expertise. Additionally, collaborations between academia, industry, and government agencies have facilitated the translation of genomic research findings into clinical applications, driving the adoption of targeted sequencing and resequencing in healthcare settings.

The applications of targeted sequencing and resequencing are vast and encompass various fields, including medical genetics, oncology, agriculture, and forensics. In medical genetics, targeted sequencing is used for the diagnosis of inherited diseases, pharmacogenomics, and prenatal screening. In oncology, targeted sequencing plays a crucial role in identifying somatic mutations associated with cancer development, predicting treatment response, and monitoring disease progression. In agriculture, targeted sequencing is utilized for crop improvement, trait mapping, and biodiversity conservation. In forensics, targeted sequencing is employed for human identification, paternity testing, and forensic DNA analysis.

Segmental Insights

Technology Insights

Based on the category of technology, Sequencing emerged as the dominant segment in the global market for Targeted Sequencing And Resequencing in 2023. Sequencing technologies have experienced a rapid evolution, characterized by increased throughput, enhanced accuracy, and reduced costs. These advancements have empowered researchers with the ability to efficiently analyze specific regions of the genome, facilitating targeted sequencing and resequencing endeavors. Next-generation sequencing (NGS) has emerged as a cornerstone technology in the field of genomics. Its high-throughput capabilities and cost-effectiveness have democratized genomic research, enabling widespread adoption across academic, clinical, and industrial sectors. NGS platforms such as Illumina's HiSeq, NovaSeq, and MiSeq have become synonymous with targeted sequencing applications, empowering researchers to explore genetic variations with unprecedented depth and scale.

Application Insights

The Clinical application segment is projected to experience rapid growth during the forecast period. Targeted sequencing enables precise analysis of specific genomic regions associated with diseases. This capability is pivotal in advancing precision medicine initiatives, where treatments are tailored to individual genetic profiles. As precision medicine gains prominence, the demand for targeted sequencing in clinical settings escalates. Targeted sequencing facilitates accurate diagnosis of genetic disorders and provides insights into disease risk assessment. Clinicians utilize this technology to identify mutations responsible for various ailments, enabling early detection and intervention. Consequently, targeted sequencing has become integral to clinical diagnostics, driving its adoption in healthcare institutions worldwide.

Download Free Sample Report

Regional Insights

North America emerged as the dominant region in the global Targeted Sequencing And Resequencing market in 2023, holding the largest market share in terms of value. North America, particularly the United States and Canada, boasts a robust ecosystem of biotechnology companies, research institutions, and academic centers focused on genomics. These entities have invested heavily in cutting-edge technologies for targeted sequencing and resequencing, driving innovation and market growth. With ample funding and resources, North American companies and research organizations lead the way in developing advanced sequencing platforms, bioinformatics tools, and applications for genomic analysis.

Recent Development

  • In May 2024, Baylor Genetics, a leading clinical diagnostic laboratory specializing in genetic testing, announced the launch of a new RNA sequencing test, RNAseq, for Whole Exome and Whole Genome Sequencing (WES/WGS). Concurrently, the company has expedited its standard turnaround time for WES and WGS to three weeks, while maintaining its capability to deliver rapid testing with written reports within as little as five days.
  • In March 2024, the World Health Organization (WHO) released new recommendations on the utilization of targeted next-generation sequencing (NGS) tests for diagnosing drug-resistant tuberculosis (TB). These recommendations are detailed in the third edition of the Consolidated Guidelines on Tuberculosis, Module 3: Diagnosis. Rapid Diagnostics for Tuberculosis Detection. This innovative approach leverages advanced technologies to rapidly identify drug resistance to new anti-TB medications.
  • In March 2024, Jammu & Kashmir inaugurated its first 'Next Generation Sequencing' (NGS) laboratories, now operational at two leading hospitals in the Jammu region: the Government Medical College and Hospital (GMC&H) in Jammu and Gandhi Nagar Hospital. Cutting-edge NGS machines have been installed at both GMC&H Jammu and Gandhi Nagar Hospital. The laboratories have initially begun testing for breast cancer, marking a significant advancement in cancer diagnostics for the region.
  • In February 2024, Wasatch Biolabs (WBL), a subsidiary of Renew Biotechnologies and an accredited Oxford Nanopore Technologies laboratory, unveiled its proprietary Targeted DNA Methylation Sequencing Service for researchers and clinical service providers. This innovative technique eliminates the need for amplification and bisulfite conversion, overcoming the common limitations of traditional targeted methylation analysis. WBL's service offers the creation of custom methylation panels targeting an unparalleled range of hundreds to thousands of genomic loci, with enrichment levels between 400x and 2300x.

Key Market Players

  • Agilent Technologies Inc.
  • Illumina, Inc.
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific, Inc.
  • DNASTAR Inc.
  • Bio-Rad Laboratories, Inc.
  • Integrated DNA Technologies, Inc.
  • Perkin Elmer, Inc.
  • RainDance Technologies, Inc.
  • Genomatix GmbH
  • Macrogen, Inc.
  • GATC Biotech Ag

By Technology

By Type

By Application

By End-use

By Region
  • Sequencing
  • Re-sequencing
  • DNA-based targeted sequencing
  • RNA-based targeted sequencing
  • Clinical application
  • Plant and animal sciences
  • Drug development
  • Others
  • Hospitals & clinics
  • Academic research
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Report Scope:

In this report, the Global Targeted Sequencing And Resequencing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Targeted Sequencing And Resequencing Market, By Technology:

o   Sequencing

o   Re-sequencing

  • Targeted Sequencing And Resequencing Market, By Type:

o   DNA-based targeted sequencing

o   RNA-based targeted sequencing

  • Targeted Sequencing And Resequencing Market, By Application:

o   Clinical application

o   Plant and animal sciences

o   Drug development

o   Others

  • Targeted Sequencing And Resequencing Market, By End - use:

o   Hospitals & clinics

o   Academic research

o   Others

  • Targeted Sequencing And Resequencing Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Targeted Sequencing And Resequencing Market.

Available Customizations:

Global Targeted Sequencing And Resequencing market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Targeted Sequencing And Resequencing Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Global Targeted Sequencing And Resequencing Market Outlook

4.1.  Market Size & Forecast

4.1.1.     By Value

4.2.  Market Share & Forecast

4.2.1.     By Technology (Sequencing, Re-sequencing( Electrophoresis-based resequencing, NGS, Array-based resequencing))

4.2.2.     By Type (DNA-based targeted sequencing, RNA-based targeted sequencing)

4.2.3.     By Application (Clinical application, Plant and animal sciences, Drug development, Others)

4.2.4.     By End use (Hospitals & clinics, Academic research, Others)

4.2.5.     By Region

4.2.6.     By Company (2023)

4.3.  Market Map

4.3.1.     By Technology

4.3.2.     By Type

4.3.3.     By Application

4.3.4.     By End use

4.3.5.     By Region

5.    Asia Pacific Targeted Sequencing And Resequencing Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Technology

5.2.2.     By Type

5.2.3.     By Application

5.2.4.     By End use

5.2.5.     By Country

5.3.  Asia Pacific: Country Analysis

5.3.1.     China Targeted Sequencing And Resequencing Market Outlook

5.3.1.1.         Market Size & Forecast

5.3.1.1.1.             By Value

5.3.1.2.         Market Share & Forecast

5.3.1.2.1.             By Technology

5.3.1.2.2.             By Type

5.3.1.2.3.             By Application

5.3.1.2.4.             By End use

5.3.2.     India Targeted Sequencing And Resequencing Market Outlook

5.3.2.1.         Market Size & Forecast

5.3.2.1.1.             By Value

5.3.2.2.         Market Share & Forecast

5.3.2.2.1.             By Technology

5.3.2.2.2.             By Type

5.3.2.2.3.             By Application

5.3.2.2.4.             By End use

5.3.3.     Australia Targeted Sequencing And Resequencing Market Outlook

5.3.3.1.         Market Size & Forecast

5.3.3.1.1.             By Value

5.3.3.2.         Market Share & Forecast

5.3.3.2.1.             By Technology

5.3.3.2.2.             By Type

5.3.3.2.3.             By Application

5.3.3.2.4.             By End use

5.3.4.     Japan Targeted Sequencing And Resequencing Market Outlook

5.3.4.1.         Market Size & Forecast

5.3.4.1.1.             By Value

5.3.4.2.         Market Share & Forecast

5.3.4.2.1.             By Technology

5.3.4.2.2.             By Type

5.3.4.2.3.             By Application

5.3.4.2.4.             By End use

5.3.5.     South Korea Targeted Sequencing And Resequencing Market Outlook

5.3.5.1.         Market Size & Forecast

5.3.5.1.1.             By Value

5.3.5.2.         Market Share & Forecast

5.3.5.2.1.             By Technology

5.3.5.2.2.             By Type

5.3.5.2.3.             By Application

5.3.5.2.4.             By End use

6.    Europe Targeted Sequencing And Resequencing Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Technology

6.2.2.     By Type

6.2.3.     By Application

6.2.4.     By End use

6.2.5.     By Country

6.3.  Europe: Country Analysis

6.3.1.     France Targeted Sequencing And Resequencing Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Technology

6.3.1.2.2.             By Type

6.3.1.2.3.             By Application

6.3.1.2.4.             By End use

6.3.2.     Germany Targeted Sequencing And Resequencing Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Technology

6.3.2.2.2.             By Type

6.3.2.2.3.              By Application

6.3.2.2.4.             By End use

6.3.3.     Spain Targeted Sequencing And Resequencing Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Technology

6.3.3.2.2.             By Type

6.3.3.2.3.             By Application

6.3.3.2.4.             By End use

6.3.4.     Italy Targeted Sequencing And Resequencing Market Outlook

6.3.4.1.         Market Size & Forecast

6.3.4.1.1.             By Value

6.3.4.2.         Market Share & Forecast

6.3.4.2.1.             By Technology

6.3.4.2.2.             By Type

6.3.4.2.3.              By Application

6.3.4.2.4.             By End use

6.3.5.     United Kingdom Targeted Sequencing And Resequencing Market Outlook

6.3.5.1.         Market Size & Forecast

6.3.5.1.1.             By Value

6.3.5.2.         Market Share & Forecast

6.3.5.2.1.             By Technology

6.3.5.2.2.             By Type

6.3.5.2.3.             By Application

6.3.5.2.4.             By End use

7.    North America Targeted Sequencing And Resequencing Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Technology

7.2.2.     By Type

7.2.3.     By Application

7.2.4.     By End use

7.2.5.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Targeted Sequencing And Resequencing Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Technology

7.3.1.2.2.             By Type

7.3.1.2.3.             By Application

7.3.1.2.4.             By End use

7.3.2.     Mexico Targeted Sequencing And Resequencing Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Technology

7.3.2.2.2.             By Type

7.3.2.2.3.             By Application

7.3.2.2.4.             By End use

7.3.3.     Canada Targeted Sequencing And Resequencing Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Technology

7.3.3.2.2.             By Type

7.3.3.2.3.              By Application

7.3.3.2.4.             By End use

8.    South America Targeted Sequencing And Resequencing Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Technology

8.2.2.     By Type

8.2.3.     By Application

8.2.4.     By End use

8.2.5.     By Country

8.3.  South America: Country Analysis

8.3.1.     Brazil Targeted Sequencing And Resequencing Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Technology

8.3.1.2.2.             By Type

8.3.1.2.3.             By Application

8.3.1.2.4.             By End use

8.3.2.     Argentina Targeted Sequencing And Resequencing Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Technology

8.3.2.2.2.             By Type

8.3.2.2.3.              By Application

8.3.2.2.4.             By End use

8.3.3.     Colombia Targeted Sequencing And Resequencing Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Technology

8.3.3.2.2.             By Type

8.3.3.2.3.             By Application

8.3.3.2.4.             By End use

9.    Middle East and Africa Targeted Sequencing And Resequencing Market Outlook

9.1.  Market Size & Forecast

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Technology

9.2.2.     By Type

9.2.3.     By Application

9.2.4.     By End use

9.2.5.     By Country

9.3.  MEA: Country Analysis

9.3.1.     South Africa Targeted Sequencing And Resequencing Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Technology

9.3.1.2.2.             By Type

9.3.1.2.3.             By Application

9.3.1.2.4.             By End use

9.3.2.     Saudi Arabia Targeted Sequencing And Resequencing Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Technology

9.3.2.2.2.             By Type

9.3.2.2.3.             By Application

9.3.2.2.4.             By End use

9.3.3.     UAE Targeted Sequencing And Resequencing Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Technology

9.3.3.2.2.             By Type

9.3.3.2.3.              By Application

9.3.3.2.4.             By End use

10.  Market Dynamics

10.1.              Drivers

10.2.              Challenges

11.  Market Trends & Developments

11.1.              Recent Developments

11.2.              Product Launches

11.3.              Mergers & Acquisitions

12.  Global Targeted Sequencing And Resequencing Market: SWOT Analysis

13.  Porter’s Five Forces Analysis

13.1.              Competition in the Industry

13.2.              Potential of New Entrants

13.3.              Power of Suppliers

13.4.              Power of Customers

13.5.              Threat of Substitute Product

14.  Competitive Landscape

14.1.    Agilent Technologies Inc.

14.1.1.          Business Overview

14.1.2.           Company Snapshot

14.1.3.           Product & Services

14.1.4.           Financials (In case of listed)

14.1.5.           Recent Developments

14.1.6.           SWOT Analysis

14.2.    Illumina, Inc.

14.3.    F. Hoffmann-La Roche Ltd

14.4.    Thermo Fisher Scientific, Inc.

14.5.    DNASTAR Inc.

14.6.    Bio-Rad Laboratories, Inc.

14.7.    Integrated DNA Technologies, Inc.

14.8.    Perkin Elmer, Inc.

14.9.    RainDance Technologies, Inc.

14.10. Genomatix Gmbh

14.11. Macrogen, Inc.

14.12. GATC Biotech Ag

15.  Strategic Recommendations

16.  About Us & Disclaimer

Figures and Tables

Frequently asked questions

down-arrow

The market size of the Global Targeted Sequencing And Resequencing Market was estimated to be USD 5.11 Billion in 2023.

down-arrow

Targeted sequencing generates large volumes of data, requiring sophisticated bioinformatics tools and skilled personnel for data analysis and interpretation. Handling and making sense of this data efficiently and accurately can be challenging.

down-arrow

Agilent Technologies Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc., DNASTAR Inc., Bio-Rad Laboratories, Inc., Integrated DNA Technologies, Inc., Perkin Elmer, Inc., RainDance Technologies, Inc., PierianDx, Genomatix GmbH, Macrogen, Inc., GATC Biotech Ag, are the top players operating in the Global Targeted Sequencing And Resequencing Market in 2023.

down-arrow

Rising investments in precision medicine and growing demand for research tools and services are the major drivers for the Global Targeted Sequencing And Resequencing Market.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Targeted Sequencing And Resequencing Market to Grow with a CAGR of 5.25% through 2029

Aug, 2024

Rising investments in precision medicine and growing demand for research tools and services are driving the Global Targeted Sequencing and Resequencing Market in the forecast period 2025-2029

Why Choose Us